User profiles for Minako Yamaoka

Minako Yamaoka-Tojo

Kitasato University
Verified email at med.kitasato-u.ac.jp
Cited by 4268

Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin

M Yamaoka, S Yamaguchi, T Suzuki… - Journal of Molecular and …, 2000 - Elsevier
M. Yamaoka, S. Yamaguchi, T. Suzuki, M. Okuyama, J. Nitobe, N. Nakamura, Y. Mitsui and H.
Tomoike. Apoptosis in Rat Cardiac Myocytes Induced by Fas Ligand: Priming for Fas-…

Anti-inflammatory Cytokine Profile in Human Heart Failure Behavior of Interleukin-10 in Association With Tumor Necrosis Factor-Alpha

M Yamaoka, S Yamaguchi, M Okuyama… - Japanese circulation …, 1999 - jstage.jst.go.jp
Proinflammatory cytokines, ie, tumor necrosis factor-alpha (TNFα), participate in the
development and the progression of congestive heart failure (CHF). On the other hand, an anti-…

Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure

S Yamaguchi, M Yamaoka, M Okuyama… - American Journal of …, 1999 - ajconline.org
Fas ligand (FasL) is a 40-kD type II transmembrane protein that is homologous to tumor
necrosis factor-(TNF-). 1 FasL induces apoptosis by binding to its membrane receptor Fas (CD95…

Serum levels of soluble form of Fas molecule in patients with congestive heart failure

…, S Yamaguchi, N Nozaki, M Yamaoka… - American Journal of …, 1997 - ajconline.org
Fas, also called APO-1, is a type I membrane protein of 45 kDa which is expressed in various
tissues and cells including the thymus, liver, ovary, lung, and heart. 1–3 Fas is a member of …

Role of gp91phox (Nox2)-Containing NAD(P)H Oxidase in Angiogenesis in Response to Hindlimb Ischemia

T Tojo, M Ushio-Fukai, M Yamaoka-Tojo, S Ikeda… - Circulation, 2005 - Am Heart Assoc
Background— Neovascularization is potentially important for the treatment of ischemic heart
and limb disease. We reported that reactive oxygen species (ROS) derived from gp91 phox (…

IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species—dependent endothelial migration and …

M Yamaoka-Tojo, M Ushio-Fukai, L Hilenski… - Circulation …, 2004 - Am Heart Assoc
Endothelial cell (EC) proliferation and migration are important for reendothelialization and
angiogenesis. We have demonstrated that reactive oxygen species (ROS) derived from the …

JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease

…, N Suzuki, D Tamaki, M Yamaoka-Tojo… - Circulation …, 2022 - jstage.jst.go.jp
Eight years have passed since the publication of the only guideline on cardiac rehabilitation
(CR) in Japan,“Guidelines for rehabilitation in patients with cardiovascular disease (JCS …

Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch

…, H Atsumi, M Yamaki, N Takahashi, M Yamaoka… - Journal of Nuclear …, 1998 - Springer
Background It has been known that Tc 99m sestamibi/iodine 123
betamethyliodophenylpentadecanoic (123 I-BMIPP)(sestamibi/BMIPP) mismatch is an indicator of …

Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease

…, E Maekawa, C Noda, M Yamaoka-Tojo… - European Journal of …, 2018 - academic.oup.com
Background Although gait speed and six-minute walk distance are used to assess functional
capacity in older patients with cardiovascular disease, their prognostic capabilities have not …

[HTML][HTML] Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19

M Yamaoka-Tojo - Biomedical journal, 2020 - Elsevier
In atherosclerosis patients, vascular endothelial dysfunction is commonly observed alongside
damage of the vascular endothelial glycocalyx, an extracellular matrix bound to and …